Nomogram predicting the risk of recurrence after curativeâ intent resection of primary nonâ metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group

Prediction of recurrence of early gastric cancer after curative resection

김기열
김성수
노성훈
라선영
오성진
이찬주
정현철
최승호

January 2009

BACKGROUND: Recurrence of early gastric cancer (EGC) after curative resection is rare, and the types...

Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis

February 2022

none9noPurpose: Patients submitted to curative surgery for non-functioning pancreatic neuroendocrine...

A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors

Genç, Cansu G.
Jilesen, Anneke P.
Partelli, Stefano
Falconi, Massimo
Muffatti, Francesca
van Kemenade, Folkert J.
van Eeden, Susanne
Verheij, Joanne
van Dieren, Susan
van Eijck, Casper H. J.
Nieveen van Dijkum, Elisabeth J. M.

January 2018

The aim of this study was to predict recurrence in patients with grade 1 or 2 nonfunctioning pancrea...

Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group

Merath, Katiuscha
Bagante, Fabio
Beal, Eliza W
Lopez-Aguiar, Alexandra G
Poultsides, George
Makris, Eleftherios
Rocha, Flavio
Kanji, Zaheer
Weber, Sharon
Fisher, Alexander
Fields, Ryan
Krasnick, Bradley A
Idrees, Kamran
Smith, Paula M
Cho, Cliff
Beems, Megan
Schmidt, Carl R
Dillhoff, Mary
Maithel, Shishir K
Pawlik, Timothy M

January 2018

Background: The risk of recurrence after resection of non-metastatic gastro-entero-pancreatic neuroe...

Multi-institutional development and external validation of a nomogram to predict recurrence after curative resection of pancreatic neuroendocrine tumors

Pulvirenti, Alessandra
Javed, Ammar A.
Landoni, Luca
Jamieson, Nigel B.
Chou, Joanne F.
Miotto, Marco
He, Jin
Gonen, Mithat
Pea, Antonio
Tang, Laura H.
Nessi, Chiara
Cingarlini, Sara
D’Angelica, Michael I.
Gill, Anthony J.
Kingham, T. Peter
Scarpa, Aldo
Weiss, Matthew J.
Balachandran, Vinod P.
Samra, Jaswinder S.
Cameron, John L.
Jarnagin, William R.
Salvia, Roberto
Wolfgang, Christopher L.
Allen, Peter J.
Bassi, Claudio

December 2021

Objective: To develop a nomogram estimating the probability of recurrence free at 5 years after re...

Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors

Pulvirenti, Alessandra
Javed, Ammar A.
Landoni, Luca
Jamieson, Nigel B.
Chou, Joanne F.
Miotto, Marco
He, Jin
Gonen, Mithat
Pea, Antonio
Tang, Laura H.
Nessi, Chiara
Cingarlini, Sara
D’Angelica, Michael I
Gill, Anthony J
Kingham, T Peter
Scarpa, Aldo
Weiss, Matthew J
Balachandran, Vinod P
Samra, Jaswinder S.
Cameron, John L.
Jarnagin, William R.
Salvia, Roberto
Wolfgang, Christopher L.
Allen, Peter J.
Bassi, Claudio

December 2021

OBJECTIVE: To develop a nomogram estimating the probability of recurrence free at 5 years after rese...

International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors

Heidsma, Charlotte M.
van Roessel, Stijn
van Dieren, Susan
Engelsman, Anton F.
Strobel, Oliver
Buechler, Markus W.
Schimmack, Simon
Perinel, Julie
Adham, Mustapha
Deshpande, Vikram
Kjaer, Josefine
Norlen, Olov
Gill, Anthony J.
Samra, Jaswinder S.
Mittal, Anubhav
Hoogwater, Frederik J. H.
Primavesi, Florian
Stattner, Stefan
Besselink, Marc G.
van Eijck, Casper H. J.
van Dijkum, E. J. M. Nieveen

May 2022

Background: Despite the low recurrence rate of resected nonfunctional pancreatic neuroendocrine tumo...

Analysis of Postoperative Recurrence in Stage I-III Midgut Neuroendocrine Tumors

Cives, Mauro
Anaya, Daniel A.
Soares, Heloisa
Coppola, Domenico
Strosberg, Jonathan

January 2018

Background: Surgery represents the only curative treatment for stage I-III midgut neuroendocrine tum...

External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer

김기열
김주훈
김효송
남정모
라선영

January 2012

BACKGROUND: Nomograms are statistics-based tools that provide the overall probability of a specific ...

Risk Factors and Predictive Score Model for Early Recurrence After Curative Surgery in Patients With Poorly Differentiated Gastrointestinal Neuroendocrine Neoplasms

Chengguo Li
Peng Zhang
Xiong Sun
Xin Tong
Xin Chen
Chong Li
Wenchang Yang
Weizhen Liu
Zheng Wang
Kaixiong Tao

September 2021

Purpose: Studies on early recurrence in gastrointestinal neuroendocrine carcinoma (NEC) and mixed ad...

Radical Resection in Entero-Pancreatic Neuroendocrine Tumors:Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence

Merola, E
Pascher, A
Rinke, A
Bartsch, D K
Zerbi, A
Nappo, G
Carnaghi, C
Ciola, M
McNamara, M G
Zandee, W
Bertani, E
Marcucci, S
Modica, R
Grützmann, R
Fazio, N
de Herder, W
Valle, J W
Gress, T M
Fave, G Delle
de Pretis, G
Perren, A
Wiedenmann, B
Pavel, M E

September 2022

BACKGROUND: Surgery with radical intent is the only potentially curative option for entero-pancreati...

The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8â institution study from the US Neuroendocrine Tumor Study Group

Zaidi, Mohammad Y.
Lopez‐aguiar, Alexandra G.
Poultsides, George A.
Dillhoff, Mary
Rocha, Flavio G.
Idrees, Kamran
Nathan, Hari
Winslow, Emily R.
Fields, Ryan C.
Cardona, Kenneth
Maithel, Shishir K.

January 2019

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/147162/1/jso25306_am.pdfhttps://deepbl...

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

Gold, J. S.
Gonen, M.
Gutierrez, A.
Broto, J. M.
Garcia-del-Muro, X.
Smyrk, T. C.
Maki, R. G.
Singer, S.
Brennan, M. F.
Antonescu, C. R.
Donohue, J. H.
DeMatteo, R. P.

November 2009

BACKGROUND: Adjuvant imatinib mesylate prolongs recurrence-free survival (RFS) after resection of lo...

Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection

Laskaratos, F-M
Liu, M
Malczewska, A
Ogunbiyi, O
Watkins, J
Luong, TV
Mandair, D
Caplin, M
Toumpanakis, C

August 2020

PURPOSE: Surgical resection is the only effective curative strategy for small intestinal neuroendocr...

Surveillance Strategy for Rectal Neuroendocrine Tumors According to Recurrence Risk Stratification

김동현
김원호
김태일
김호근
박수정
천재희
홍성필

January 2014

BACKGROUND/AIM: Rectal neuroendocrine tumors (NETs) have been increasing in incidence. However, the ...

Prediction of recurrence of early gastric cancer after curative resection

김기열
김성수
노성훈
라선영
오성진
이찬주
정현철
최승호

January 2009

BACKGROUND: Recurrence of early gastric cancer (EGC) after curative resection is rare, and the types...

Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis

February 2022

none9noPurpose: Patients submitted to curative surgery for non-functioning pancreatic neuroendocrine...

A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors

Genç, Cansu G.
Jilesen, Anneke P.
Partelli, Stefano
Falconi, Massimo
Muffatti, Francesca
van Kemenade, Folkert J.
van Eeden, Susanne
Verheij, Joanne
van Dieren, Susan
van Eijck, Casper H. J.
Nieveen van Dijkum, Elisabeth J. M.

January 2018

The aim of this study was to predict recurrence in patients with grade 1 or 2 nonfunctioning pancrea...

Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group

Merath, Katiuscha
Bagante, Fabio
Beal, Eliza W
Lopez-Aguiar, Alexandra G
Poultsides, George
Makris, Eleftherios
Rocha, Flavio
Kanji, Zaheer
Weber, Sharon
Fisher, Alexander
Fields, Ryan
Krasnick, Bradley A
Idrees, Kamran
Smith, Paula M
Cho, Cliff
Beems, Megan
Schmidt, Carl R
Dillhoff, Mary
Maithel, Shishir K
Pawlik, Timothy M

January 2018

Background: The risk of recurrence after resection of non-metastatic gastro-entero-pancreatic neuroe...

Multi-institutional development and external validation of a nomogram to predict recurrence after curative resection of pancreatic neuroendocrine tumors

Pulvirenti, Alessandra
Javed, Ammar A.
Landoni, Luca
Jamieson, Nigel B.
Chou, Joanne F.
Miotto, Marco
He, Jin
Gonen, Mithat
Pea, Antonio
Tang, Laura H.
Nessi, Chiara
Cingarlini, Sara
D’Angelica, Michael I.
Gill, Anthony J.
Kingham, T. Peter
Scarpa, Aldo
Weiss, Matthew J.
Balachandran, Vinod P.
Samra, Jaswinder S.
Cameron, John L.
Jarnagin, William R.
Salvia, Roberto
Wolfgang, Christopher L.
Allen, Peter J.
Bassi, Claudio

December 2021

Objective: To develop a nomogram estimating the probability of recurrence free at 5 years after re...

Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors

Pulvirenti, Alessandra
Javed, Ammar A.
Landoni, Luca
Jamieson, Nigel B.
Chou, Joanne F.
Miotto, Marco
He, Jin
Gonen, Mithat
Pea, Antonio
Tang, Laura H.
Nessi, Chiara
Cingarlini, Sara
D’Angelica, Michael I
Gill, Anthony J
Kingham, T Peter
Scarpa, Aldo
Weiss, Matthew J
Balachandran, Vinod P
Samra, Jaswinder S.
Cameron, John L.
Jarnagin, William R.
Salvia, Roberto
Wolfgang, Christopher L.
Allen, Peter J.
Bassi, Claudio

December 2021

OBJECTIVE: To develop a nomogram estimating the probability of recurrence free at 5 years after rese...

International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors

Heidsma, Charlotte M.
van Roessel, Stijn
van Dieren, Susan
Engelsman, Anton F.
Strobel, Oliver
Buechler, Markus W.
Schimmack, Simon
Perinel, Julie
Adham, Mustapha
Deshpande, Vikram
Kjaer, Josefine
Norlen, Olov
Gill, Anthony J.
Samra, Jaswinder S.
Mittal, Anubhav
Hoogwater, Frederik J. H.
Primavesi, Florian
Stattner, Stefan
Besselink, Marc G.
van Eijck, Casper H. J.
van Dijkum, E. J. M. Nieveen

May 2022

Background: Despite the low recurrence rate of resected nonfunctional pancreatic neuroendocrine tumo...

Analysis of Postoperative Recurrence in Stage I-III Midgut Neuroendocrine Tumors

Cives, Mauro
Anaya, Daniel A.
Soares, Heloisa
Coppola, Domenico
Strosberg, Jonathan

January 2018

Background: Surgery represents the only curative treatment for stage I-III midgut neuroendocrine tum...

External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer

김기열
김주훈
김효송
남정모
라선영

January 2012

BACKGROUND: Nomograms are statistics-based tools that provide the overall probability of a specific ...

Risk Factors and Predictive Score Model for Early Recurrence After Curative Surgery in Patients With Poorly Differentiated Gastrointestinal Neuroendocrine Neoplasms

Chengguo Li
Peng Zhang
Xiong Sun
Xin Tong
Xin Chen
Chong Li
Wenchang Yang
Weizhen Liu
Zheng Wang
Kaixiong Tao

September 2021

Purpose: Studies on early recurrence in gastrointestinal neuroendocrine carcinoma (NEC) and mixed ad...

Radical Resection in Entero-Pancreatic Neuroendocrine Tumors:Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence

Merola, E
Pascher, A
Rinke, A
Bartsch, D K
Zerbi, A
Nappo, G
Carnaghi, C
Ciola, M
McNamara, M G
Zandee, W
Bertani, E
Marcucci, S
Modica, R
Grützmann, R
Fazio, N
de Herder, W
Valle, J W
Gress, T M
Fave, G Delle
de Pretis, G
Perren, A
Wiedenmann, B
Pavel, M E

September 2022

BACKGROUND: Surgery with radical intent is the only potentially curative option for entero-pancreati...

The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8â institution study from the US Neuroendocrine Tumor Study Group

Zaidi, Mohammad Y.
Lopez‐aguiar, Alexandra G.
Poultsides, George A.
Dillhoff, Mary
Rocha, Flavio G.
Idrees, Kamran
Nathan, Hari
Winslow, Emily R.
Fields, Ryan C.
Cardona, Kenneth
Maithel, Shishir K.

January 2019

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/147162/1/jso25306_am.pdfhttps://deepbl...

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

Gold, J. S.
Gonen, M.
Gutierrez, A.
Broto, J. M.
Garcia-del-Muro, X.
Smyrk, T. C.
Maki, R. G.
Singer, S.
Brennan, M. F.
Antonescu, C. R.
Donohue, J. H.
DeMatteo, R. P.

November 2009

BACKGROUND: Adjuvant imatinib mesylate prolongs recurrence-free survival (RFS) after resection of lo...

Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection

Laskaratos, F-M
Liu, M
Malczewska, A
Ogunbiyi, O
Watkins, J
Luong, TV
Mandair, D
Caplin, M
Toumpanakis, C

August 2020

PURPOSE: Surgical resection is the only effective curative strategy for small intestinal neuroendocr...

Surveillance Strategy for Rectal Neuroendocrine Tumors According to Recurrence Risk Stratification

김동현
김원호
김태일
김호근
박수정
천재희
홍성필

January 2014

BACKGROUND/AIM: Rectal neuroendocrine tumors (NETs) have been increasing in incidence. However, the ...

Prediction of recurrence of early gastric cancer after curative resection

김기열
김성수
노성훈
라선영
오성진
이찬주
정현철
최승호

January 2009

BACKGROUND: Recurrence of early gastric cancer (EGC) after curative resection is rare, and the types...

Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis

February 2022

none9noPurpose: Patients submitted to curative surgery for non-functioning pancreatic neuroendocrine...

A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors

Genç, Cansu G.
Jilesen, Anneke P.
Partelli, Stefano
Falconi, Massimo
Muffatti, Francesca
van Kemenade, Folkert J.
van Eeden, Susanne
Verheij, Joanne
van Dieren, Susan
van Eijck, Casper H. J.
Nieveen van Dijkum, Elisabeth J. M.

January 2018

The aim of this study was to predict recurrence in patients with grade 1 or 2 nonfunctioning pancrea...

Nomogram predicting the risk of recurrence after curativeâ intent resection of primary nonâ metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group

Abstract

Extracted data

Nomogram predicting the risk of recurrence after curativeâ intent resection of primary nonâ metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group

Abstract

Extracted data

Related items

Related items